0.1000GBp-25.93%Mkt Cap: 4.66M $P/E: —1d ago
Oxford BioDynamics Plc, together with its subsidiaries, operates as a biotechnology company that y developing, and commercializing precision medicine tests for life-changing diseases in the United States and the United K…
Indicators:|
Key Statistics
Company
Market Cap4.66M $
Enterprise Value8.71M $
Revenue (TTM)1.19M $
Gross Profit567.39K $
Net Income (TTM)-12.12M $
Revenue/Share0.0011 USD
Last Price0.1000 GBp
Fiscal Year EndSep 2025
MR QuarterSep 2025
Employees41
CountryGB
SectorHealthcare
IndustryDiagnostics & Research
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-0.25
PEG—
EV/EBITDA-0.78
EV/Revenue7.31
P/S3.92
P/B1.00
EPS (TTM)-0.01
EPS (Forward)-0.00
52W Range
0.08003% of range0.7800
52W High0.7800 GBp
52W Low0.0800 GBp
Profitability
Gross Margin47.67%
Oper. Margin-958.86%
EBITDA Margin0.00%
Profit Margin-1018.54%
ROE-999.37%
ROA-137.93%
Growth
Revenue Growth64.40%
Earnings Growth—
Cash Flow & Leverage
Operating CF-8.23M $
CapEx (TTM)265.22K $
FCF Margin-394.79%
FCF Yield-100.75%
Net Debt4.04M $
Net Debt/EBITDA-0.36
Balance Sheet
Debt/Equity4.58
Current Ratio0.88
Quick Ratio0.76
Book Value/Sh0.0010 GBp
Cash/Share0.0000 GBp
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 GBp
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)1.000 GBp
Upside (mean)+900.0%
Target Range1.000 GBp – 1.000 GBp
# Analysts1
Ownership
Shares Out.4.29B
Float3.06B
Insiders9.87%
Institutions42.97%
Technical
SMA 500.1888 (-47.0%)
SMA 2000.2687 (-62.8%)
Beta-0.17
S&P 52W Chg20.05%
Avg Vol (30d)13.41M
Avg Vol (10d)16.13M
Technical Indicators
RSI (14)25.5
MACD-0.0137
MACD Signal-0.0078
MACD Hist.-0.0059
BB Upper0.2153 GBp
BB Middle0.1713 GBp
BB Lower0.1274 GBp
BB Width51.30%
ATR (14)0.0302 GBp
Vol Ratio (20d)14.95x